Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vacuolar protein sorting 33B pseudogene is a non-protein-coding genomic element related by sequence to the protein-coding gene VPS33B. Pseudogenes arise from gene duplication or retrotransposition events and typically harbor disabling mutations that prevent protein production[5][2][3]. While the coding VPS33B gene is involved in vesicle-mediated protein sorting and associated with multisystem syndromes[1][4][7], the pseudogene itself does not encode a functional protein and is not recognized as a drug target. Pseudogenes may play limited roles in regulating parental gene expression at the RNA or epigenetic level, but there is no evidence for the vacuolar protein sorting 33B pseudogene participating in such mechanisms in a clinically relevant way[5][3][6][9].
None (since it is not a therapeutic target, there are no mechanisms of action for drug interaction).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vacuolar protein sorting 33B pseudogene.